堅朗五金(002791.SZ):目前公司在建項目主要有東莞總部三廠等
格隆匯7月5日丨堅朗五金(002791.SZ)披露投資者關係活動記錄表顯示,目前公司在建的項目主要有東莞總部三廠、河南華北生產基地及中山小欖生產基地,每個項目投資建設的產業和進度不同。其中,河南基地主要圍繞工程類產業佈局,產業特點需要大跨度的生產廠房,現在有部分已投產,正在建設的裝配式金屬裝飾板和精緻鋼兩個產業預計在年底基建完成,並進入試生產階段;總部三廠是智能家居及智慧安防產品製造項目,目前一期處於基建階段,公司會根據產業規劃需要分批實施建設;中山小欖項目主要圍繞旗下自有及控股產業為核心擴產投資,如機械鎖、智能鎖、淋浴房及照明產業,也是公司定增募投項目的重要組成部分。目前都在正常推進中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.